"La Clinique Générale Annecy est un établissement de santé pluridisciplinaire situé à Annexy, en Auvergne-Rhône-Alpes. Elle fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Clinique Générale d'Annecy conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Générale d'Annecy" #1 sponsor was "UNICANCER" with 2 trials, followed by "University Hospital, Grenoble" with 2 trials sponsored, "Zimmer Biomet" with 2 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 1 trials sponsored and "Clinique Générale dAnnecy" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Générale d'Annecy" #1 collaborator was "Biomet France SARL" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator and "Ipsen" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Générale d'Annecy" are "Arthritis" (2 trials), "Peripheral Arterial Disease" (2 trials), "Angioplasty" (1 trials), "Cuff Tear Arthropathy" (1 trials) and "Drug-eluting Balloon" (1 trials). Many other conditions were trialed in "Clinique Générale d'Annecy" in a lesser frequency.

Most popular intervention types in "Clinique Générale d'Annecy" are "Other" (5 trials), "Device" (4 trials), "Drug" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Androgen Deprivation Therapy" (1 trials), "Antenatal identification of fetal growth restriction" (1 trials), "Biomodulation (non-pharmacological)" (1 trials), "Delta Xtend Reverse Total Shoulder" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Générale d'Annecy" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Générale d'Annecy". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinique Générale d'Annecy, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Générale d'Annecy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".